PAHC icon

Phibro Animal Health

21.97 USD
+0.61
2.86%
At close Apr 1, 4:00 PM EDT
After hours
22.00
+0.03
0.14%
1 day
2.86%
5 days
1.43%
1 month
-10.40%
3 months
5.98%
6 months
-0.50%
Year to date
5.98%
1 year
74.23%
5 years
-7.92%
10 years
-38.41%
 

About: Phibro Animal Health Corp operates as a diversified animal health and mineral nutrition company. It develops, manufactures, and markets products for a range of food animals comprising poultry, swine, beef and dairy cattle, and aquaculture. The product portfolio of the company includes animal health products such as antibacterials, anticoccidials, nutritional specialty products and vaccines, and mineral nutrition products. The company operates through three segments, Animal Health, Mineral Nutrition, and Performance Products, of which key revenue is derived from the Animal Health segment which relates to the development, manufacturing, and marketing of antibacterials, nutritional specialty products, and vaccines. The entity sells its products in the U.S. and other international countries.

Employees: 1,940

0
Funds holding %
of 7,398 funds
Analysts bullish %

Fund manager confidence

Based on 2024 Q4 regulatory filings by fund managers ($100M+ AUM)

153% more first-time investments, than exits

New positions opened: 43 | Existing positions closed: 17

76% more repeat investments, than reductions

Existing positions increased: 65 | Existing positions reduced: 37

17% more funds holding

Funds holding: 146 [Q3] → 171 (+25) [Q4]

2.25% more ownership

Funds ownership: 99.79% [Q3] → 102.04% (+2.25%) [Q4]

5% less capital invested

Capital invested by funds: $457M [Q3] → $436M (-$21.3M) [Q4]

Research analyst outlook

1 Wall Street Analyst provided 1 year price targets over the past 3 months

Low target
$22
0%
upside
Avg. target
$22
0%
upside
High target
$22
0%
upside

1 analyst rating

positive
0%
neutral
0%
negative
100%
Barclays
Balaji Prasad
30% 1-year accuracy
13 / 44 met price target
0%upside
$22
Underweight
Maintained
10 Feb 2025

Financial journalist opinion

Based on 11 articles about PAHC published over the past 30 days

Positive
Zacks Investment Research
1 day ago
PAHC vs. BSX: Which Stock Is the Better Value Option?
Investors interested in stocks from the Medical - Products sector have probably already heard of Phibro Animal Health (PAHC) and Boston Scientific (BSX). But which of these two companies is the best option for those looking for undervalued stocks?
PAHC vs. BSX: Which Stock Is the Better Value Option?
Positive
Zacks Investment Research
1 day ago
Is Phibro Animal Health (PAHC) Stock Undervalued Right Now?
Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest value, growth, and momentum trends to underscore strong picks.
Is Phibro Animal Health (PAHC) Stock Undervalued Right Now?
Positive
Zacks Investment Research
6 days ago
3 Undervalued MedTech Stocks to Buy for 2025 Gains Amid S&P 500 Rally
Three discounted MedTech stocks to gain from the market rebound are PAHC, FMS and INMD.
3 Undervalued MedTech Stocks to Buy for 2025 Gains Amid S&P 500 Rally
Positive
Zacks Investment Research
6 days ago
Should You Bet on PAHC Stock at a Discounted P/E of 10.41X?
PAHC's solid MFA franchise, now bolstered by Zoetis' portfolio, makes it a solid investment case. A well-established foothold in key regions is also a factor.
Should You Bet on PAHC Stock at a Discounted P/E of 10.41X?
Positive
Zacks Investment Research
1 week ago
Looking for a Growth Stock? 3 Reasons Why Phibro (PAHC) is a Solid Choice
Phibro (PAHC) possesses solid growth attributes, which could help it handily outperform the market.
Looking for a Growth Stock? 3 Reasons Why Phibro (PAHC) is a Solid Choice
Positive
Zacks Investment Research
2 weeks ago
PAHC vs. BSX: Which Stock Should Value Investors Buy Now?
Investors with an interest in Medical - Products stocks have likely encountered both Phibro Animal Health (PAHC) and Boston Scientific (BSX). But which of these two stocks offers value investors a better bang for their buck right now?
PAHC vs. BSX: Which Stock Should Value Investors Buy Now?
Positive
Zacks Investment Research
2 weeks ago
Is Phibro Animal Health (PAHC) a Great Value Stock Right Now?
Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest value, growth, and momentum trends to underscore strong picks.
Is Phibro Animal Health (PAHC) a Great Value Stock Right Now?
Neutral
Zacks Investment Research
3 weeks ago
Phibro Animal Health Stock Up 87.5% in a Year: What's Driving the Rise?
PAHC stays on investors' radar due to its Animal Health business and potential in emerging markets.
Phibro Animal Health Stock Up 87.5% in a Year: What's Driving the Rise?
Negative
Zacks Investment Research
3 weeks ago
Why Is Phibro (PAHC) Down 5.2% Since Last Earnings Report?
Phibro (PAHC) reported earnings 30 days ago. What's next for the stock?
Why Is Phibro (PAHC) Down 5.2% Since Last Earnings Report?
Neutral
Business Wire
3 weeks ago
Phibro Animal Health Corporation to Participate at Barclays Annual Global Healthcare Conference
TEANECK, N.J.--(BUSINESS WIRE)--Phibro Animal Health Corporation (Nasdaq: PAHC) announced today it will participate in the Barclays Annual Global Healthcare Conference. Chief Financial Officer, Glenn David will address financial analysts and investors on Thursday, March 13, 2025, at 9:00 AM ET at the Loews Miami Beach Hotel. The live audio presentation will be available on the Phibro Animal Health Corporation Investor Relations Website at https://investors.pahc.com. A replay of the session will.
Phibro Animal Health Corporation to Participate at Barclays Annual Global Healthcare Conference
Charts implemented using Lightweight Charts™